publication venue for
- Development and Pharmacochemical Characterization Discover a Novel Brain-Permeable HDAC11-Selective Inhibitor with Therapeutic Potential by Regulating Neuroinflammation in Mice.. 66:16075-16090. 2023
- A Novel Brain PET Radiotracer for Imaging Alpha Synuclein Fibrils in Multiple System Atrophy.. 66:12185-12202. 2023
- In Silico. 66:10628-10638. 2023
- Visualization of Receptor-Interacting Protein Kinase 1 (RIPK1) by Brain Imaging with Positron Emission Tomography.. 64:15420-15428. 2021
- Cyanobacterial peptides as a prototype for the design of potent β-secretase inhibitors and the development of selective chemical probes for other aspartic proteases.. 55:10749-65. 2012
- Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152).. 55:4101-13. 2012
- Chemistry and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.. 55:717-24. 2012
- Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitors.. 54:2952-60. 2011
- Discovery of isoxazole analogues of sazetidine-A as selective α4β2-nicotinic acetylcholine receptor partial agonists for the treatment of depression.. 54:7280-8. 2011
- Acylpyrogallols as inhibitors of antiapoptotic Bcl-2 proteins.. 51:717-20. 2008
- Pyrogallol-based molecules as potent inhibitors of the antiapoptotic Bcl-2 proteins.. 50:1723-6. 2007
- Structure-based design of flavonoid compounds as a new class of small-molecule inhibitors of the anti-apoptotic Bcl-2 proteins.. 50:3163-6. 2007
- Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins.. 49:6139-42. 2006
- Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting beta-amyloid plaques in the brain.. 46:237-43. 2003